Product Description: Ziresovir (AK0529;RO-0529) is a potent, selective, and orally bioavailable respiratory syncytial virus (RSV) fusion (F) protein (RSV F) protein inhibitor. Ziresovir shows anti-RSV activity (EC50=3 nM) and highlights pharmacokinetics in animal species[1].
Applications: COVID-19-anti-virus
Formula: C22H25N5O3S
References: [1]Zheng X, et al. Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor. J Med Chem. 2019 Jul 11;62(13):6003-6014.
CAS Number: 1422500-60-4
Molecular Weight: 439.53
Compound Purity: 95.51
Research Area: Infection
Solubility: DMSO : 125 mg/mL (ultrasonic)
Target: RSV